CSRNP3 is a nuclear transcription factor that binds the consensus DNA sequence 5'-AGAGTG-3' and functions as a transcriptional activator [UniProt annotation]. The protein localizes to the nucleus where it exhibits DNA-binding transcription factor activity specific to RNA polymerase II, enabling positive regulation of transcription and apoptotic processes [GO annotations]. Clinically, CSRNP3 has emerged as a candidate gene linked to multiple disease processes. In Alzheimer's disease, CSRNP3 was identified as a significant transcription factor whose alterations correlate with protein changes in the hippocampus, suggesting involvement in AD pathogenesis and potential therapeutic targeting 1. Additionally, CSRNP3 was identified as a susceptibility locus for metabolic syndrome in Japanese populations, implicating it in metabolic disease etiology 2. At the agricultural genomics level, CSRNP3 was among genes reshaped through human-mediated artificial selection in pig breeding, where it may contribute to phenotypic traits including body size and feed conversion efficiency 3. Finally, CSRNP3 showed altered expression in rat cardiovascular control centers in response to high-salt diet challenge, suggesting potential involvement in salt-sensitive hypertension pathogenesis 4. These findings position CSRNP3 as a multifunctional transcriptional regulator with relevance to neurodegeneration, metabolic disorders, and cardiovascular physiology.